T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
Amazon
AMZN
|
+$3.55B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.02B |
| 3 |
EQT Corp
EQT
|
+$1.52B |
| 4 |
Adobe
ADBE
|
+$1.29B |
| 5 |
Constellation Energy
CEG
|
+$1.16B |
Top Sells
| 1 |
Microsoft
MSFT
|
+$2.09B |
| 2 |
UnitedHealth
UNH
|
+$1.75B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.69B |
| 4 |
Ross Stores
ROST
|
+$1.64B |
| 5 |
ASML
ASML
|
+$1.59B |
Sector Composition
| 1 | Technology | 31.66% |
| 2 | Healthcare | 16.93% |
| 3 | Consumer Discretionary | 11.06% |
| 4 | Financials | 10.59% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMAM
1001
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $15.3M | ﹤0.01% |
929,317
+718,690
| +341% | +$11.8M |
|
1002
Restaurant Brands International
QSR
$20.8B
| $15.2M | ﹤0.01% |
196,274
-27,996
| -12% | -$2.17M |
|
1003
Cognex
CGNX
$7.55B
| $15.2M | ﹤0.01% |
270,903
-71,900
| -21% | -$4.03M |
|
1004
RXO
RXO
$2.81B
| $15.1M | ﹤0.01% |
668,127
+156,871
| +31% | +$3.56M |
|
1005
C.H. Robinson
CHRW
$15.5B
| $15M | ﹤0.01% |
159,193
-1,401,407
| -90% | -$132M |
|
1006
Suzano
SUZ
$11.8B
| $14.9M | ﹤0.01% |
+1,610,671
| New | +$14.9M |
|
1007
Catalyst Pharmaceutical
CPRX
$2.48B
| $14.8M | ﹤0.01% |
1,101,390
+71,711
| +7% | +$964K |
|
1008
Universal Health Services
UHS
$12.1B
| $14.7M | ﹤0.01% |
93,226
-1,214
| -1% | -$192K |
|
1009
Healthpeak Properties
DOC
$12.6B
| $14.7M | ﹤0.01% |
730,155
+1,615
| +0.2% | +$32.5K |
|
|
CNTA
1010
Centessa Pharmaceuticals
CNTA
$3.04B
| $14.6M | ﹤0.01% |
2,363,211
+49,778
| +2% | +$308K |
|
1011
KBR
KBR
$6.38B
| $14.5M | ﹤0.01% |
223,515
+2,709
| +1% | +$176K |
|
1012
First American
FAF
$6.93B
| $14.4M | ﹤0.01% |
252,944
+1,020
| +0.4% | +$58.2K |
|
1013
Gibraltar Industries
ROCK
$1.84B
| $14.4M | ﹤0.01% |
228,075
+9,169
| +4% | +$577K |
|
1014
Voyager Therapeutics
VYGR
$243M
| $14.1M | ﹤0.01% |
1,229,981
+328,516
| +36% | +$3.76M |
|
|
JNPR
1015
DELISTED
Juniper Networks
JNPR
| $13.9M | ﹤0.01% |
443,694
-1,171
| -0.3% | -$36.7K |
|
1016
Warner Music
WMG
$17.8B
| $13.9M | ﹤0.01% |
532,184
-63,147
| -11% | -$1.65M |
|
1017
LCI Industries
LCII
$2.52B
| $13.8M | ﹤0.01% |
109,315
+2,003
| +2% | +$253K |
|
1018
Pentair
PNR
$18.5B
| $13.8M | ﹤0.01% |
213,460
| – | – |
|
1019
Vistra
VST
$69.1B
| $13.6M | ﹤0.01% |
518,397
-11,981
| -2% | -$315K |
|
1020
Tapestry
TPR
$22.2B
| $13.6M | ﹤0.01% |
317,728
-4,436
| -1% | -$190K |
|
1021
Qorvo
QRVO
$8.12B
| $13.5M | ﹤0.01% |
132,164
-271,952
| -67% | -$27.7M |
|
|
PYCR
1022
DELISTED
Paycor HCM, Inc. Common Stock
PYCR
| $13.5M | ﹤0.01% |
569,695
-513
| -0.1% | -$12.1K |
|
|
ETRN
1023
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $13.5M | ﹤0.01% |
1,407,239
-11,907,479
| -89% | -$114M |
|
1024
Patrick Industries
PATK
$3.79B
| $13.4M | ﹤0.01% |
252,102
+81,274
| +48% | +$4.33M |
|
|
AZPN
1025
DELISTED
Aspen Technology Inc
AZPN
| $13.4M | ﹤0.01% |
80,048
-75,327
| -48% | -$12.6M |
|